These results suggested that double KO of TP53/MED12 and co-OE of HDAC5, NPM1, DTX3, and PPP3R1 functionally enhanced migration and invasion potential of gastric cancer cells, facilitated EMT and increased the resistance against standard cytotoxic chemotherapeutic drugs for gastric cancer. The gene discussed is HDAC5; the disease is gastric cancer.